PE anti-mouse IL-17A Antibody

Pricing & Availability
Clone
TC11-18H10.1 (See other available formats)
Other Names
Interleukin-17, Cytotoxic T lymphocyte-associated antigen 8 (CTLA-8)
Isotype
Rat IgG1, κ
Ave. Rating
Submit a Review
Product Citations
publications
TC11-18H10.1_PE_041910
PMA/ionomycin-stimulated (5 hours) Th17 polarized C57BL/6 mouse CD4+ T cells surface stained with CD4 (GK1.5) APC, then intracellularly stained with TC11-18H10.1 PE
  • TC11-18H10.1_PE_041910
    PMA/ionomycin-stimulated (5 hours) Th17 polarized C57BL/6 mouse CD4+ T cells surface stained with CD4 (GK1.5) APC, then intracellularly stained with TC11-18H10.1 PE
  • TC11-18H10_PE_060806
    PMA (20 ng/ml) + ionomycin (1 µg/ml) -stimulated (6 hours + monensin, 2 µM) mouse thymoma cell line EL-4 intracellularly stained with TC11-18H10.1 PE
See PE spectral data
Cat # Size Price Quantity Avail. Save
506903 25 µg $90
Check Availability


Need larger quantities of this item?
Request Bulk Quote
506904 100 µg $230
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

IL-17, also known as CTLA-8, is a T cell-expressed pleiotropic cytokine that exhibits a high degree of homology to a protein encoded by the ORF13 gene of herpes virus Saimiri. IL-17 is produced by Th cells (Th17) that are distinct from the traditional Th1- and Th2-cell subsets. IL-23 plays an important role in triggering IL-17 production. Both recombinant and natural IL-17 have been shown to exist as disulfide linked homodimers. IL-17 exhibits multiple biological activities on a variety of cells including: the induction of IL-6 and IL-8 production in fibroblasts, activation of NF-κB, and costimulation of T cell proliferation. IL-17 is an essential inflammatory mediator in the development of autoimmune diseases. Neutralization of IL-17 with monoclonal antibody is able to ameliorate the disease course.

Product Details
Technical data sheet

Product Details

Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
E. coli expressed, recombinant mouse IL-17A
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The IL-17A antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

ICFC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by intracellular immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.25 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

ELISA Capture3,4 and ELISPOT Capture5: The purified TC11-18H10.1 antibody is useful as the capture antibody in a sandwich ELISA, when used in conjunction with the biotinylated TC11-8H4 antibody (Cat. No. 507002) as the detecting antibody and recombinant mouse IL-17 (Cat. No. 576009) as the standard.
Flow Cytometry2-4,7,8,11,12: The TC11-18H10.1 antibody is useful for intracellular immunofluorescent staining and flow cytometric analysis to identify IL-17-producing cells within mixed cell populations.
Neutralization6,9: The LEAF™ purified antibody (Endotoxin <0.1 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for neutralization of mouse IL-17 bioactivity in vivo and in vitro (Cat. No. 506906).

Application References

(PubMed link indicates BioLegend citation)
  1. Kennedy J, et al. 1996. J. Interferon Cytokine Res. 16:611.
  2. Schubert D, et al. 2004. J. Immunol. 172:4503. (ICFC)
  3. Infante-Duarte C, et al. 2000. J. Immunol. 165:6107. (ICFC, ELISA Capture)
  4. Harrington LE, et al. 2005. Nature Immunol. doi:10.1038/ni1254. (ICFC, ELISA Capture)
  5. Nekrasova T, et al. 2005. J. Immunol. 175:2734. (ELISPOT Capture)
  6. Yen D, et al. 2006. J. Clin. Invest. 116:1310. (Neut)
  7. Ehirchiou D, et al. 2007. J. Exp. Med. 204:1519. (ICFC)
  8. Kang SG, et al. 2007. J. Immunol. 179:3724. (ICFC)
  9. Smith E, et al. 2008. J. Immunol. 181:1357. (Neut) PubMed
  10. Neufert C, et al. 2007. Eur. J. Immunol. 37:1809. PubMed
  11. Wang C, et al. 2009. Mucosal Immunol 2:173. (ICFC) PubMed
  12. Cui Y, et al. 2009. Invest. Ophth. Vis. Sci. 50:5811. (ICFC) PubMed
  13. Kivisäkk P, et al. 2009. Ann. Neurol. 65:457. PubMed
  14. Cooney LA, et al. 2011. J. Immunol. 187:4440. PubMed
  15. Ma Y, et al. 2012. PLoS One. 7:e40763. PubMed
  16. Murakami R, et al. 2013. PLoS One. 8:73270. PubMed
Product Citations
  1. Bankoti R, et al. 2017. Sci Rep. 10.1038/s41598-017-12171-3. PubMed
  2. Chatterjee S et al. 2017. Cell metabolism. 27(1):85-100 . PubMed
  3. Van Dis E, et al. 2018. Cell Rep. 23:1435. PubMed
  4. Dar HY, et al. 2018. Sci Rep. 8:2503. PubMed
  5. Dar HY, et al. 2018. Bone Rep. 8:46. PubMed
  6. Metidji A et al. 2018. Immunity. 49(2):353-362 . PubMed
  7. Lu Y, et al. 2018. Cancer Cell. 33:1048. PubMed
  8. Bing Wu et al. 2018. Immunity. 49(5):886-898 . PubMed
  9. Ogawa C et al. 2018. Cell reports. 25(1):19-28 . PubMed
  10. Kang YH, et al. 2019. Nat Commun. 10:912. PubMed
  11. Colliou N, et al. 2018. Gut Microbes. 9:279. PubMed
  12. Ramakrishnan SK, et al. 2019. Nat Commun. 10:660. PubMed
  13. Wu J et al. 2017. Immunity. 47(6):1114-1128 . PubMed
  14. Castro‐Dopico T et al. 2019. Immunity. 50(4):1099-1114 . PubMed
  15. Laura C Burzynski et al. 2019. Immunity. 50(4):1033-1042 . PubMed
  16. Lu Y, et al. 2019. Int J Mol Med. 43:2398. PubMed
  17. Han Y et al. 2019. Cell reports. 27(3):835-846 . PubMed
  18. Katagiri T, et al. 2019. Mucosal Immunol. 12:p1104. PubMed
  19. Luo Y et al. 2019. Cell reports. 26(7):1869-1879 . PubMed
  20. Britton GJ et al. 2019. Immunity. 50(1):212-224 . PubMed
  21. Luck H, et al. 2019. Nat Commun. 10:3650. PubMed
  22. Tian D, et al. 2019. Nat Commun. 10:4246. PubMed
  23. Yang C, et al. 2018. J Immunol. 200:1316. PubMed
  24. Saleh MM, et al. 2019. Cell Host Microbe. 25:756. PubMed
  25. Kenichi Shimada et al. 2018. Immunity. 49(5):873-885 . PubMed
  26. Zegarra‐Ruiz DF et al. 2018. Cell host & microbe. 25(1):113-127 . PubMed
  27. Sanchez M et al. 2017. Cell host & microbe. 22(4):543-551 . PubMed
  28. Liu QZ, et al. 2018. Front Immunol. 1.131944444. PubMed
  29. Piper CJM, et al. 2020. Cell Reports. 29(7):1878-1892.e7.. PubMed
  30. Angiari S, et al. 2020. Cell Metab. 31:391. PubMed
  31. Kimura S, et al. 2020. Nat Commun. 0.620833333. PubMed
  32. Suhail A, et al. 2019. Cell Rep. 29:3522. PubMed
  33. Ouyang S, et al. 2019. J Immunol. 202:1441. PubMed
  34. Liu YJ, et al. 2020. Theranostics. 10:5225. PubMed
  35. Gorman JA, et al. 2019. Front Immunol. 10:44. PubMed
  36. Lai NY, et al. 2020. Cell. 180:33:00. PubMed
  37. Xiao S, et al. 2020. Cell Reports. 32(2):107892. PubMed
  38. Castro–Dopico T, et al. 2020. Cell Reports. 32(1):107857. PubMed
  39. He J, et al. 2020. Cell Reports. 29(9):2718-2730.e6.. PubMed
  40. Vono M, et al. 2020. Cell Reports. 28(7):1773-1784.e5.. PubMed
  41. Ge Y, et al. 2020. Mucosal Immunol. 13:34. PubMed
  42. Wang N, et al. 2020. Front Immunol. 1.765972222. PubMed
  43. Kang S, et al. 2007. J Immunol. 179:3724. PubMed
  44. Ehirchiou D, et al. 2007. J Exp Med . 204:1519. PubMed
  45. Park S, et al. 2011. J Immunol. 187:5813. PubMed
  46. Mizutani N, et al. 2012. J Immunol. 188:5694. PubMed
  47. Niwa H, et al. 2009. Clin Immunol. 132:184. PubMed
  48. Kawashima H, et al. 2013. J Immunol. 191:3614. PubMed
  49. Takeuchi H, et al. 2013. J Immunol. 191:3725. PubMed
  50. Li J, et al. 2012. Arthritis Rheum. 64:1098. PubMed
  51. Li C, et al. 2014. J Immunol. 192:1425. PubMed
  52. Bhattacharya D, et al. 2014. J Biol Chem. 289:16508. PubMed
  53. Kuwahara M, et al. 2014. Nat Commun. 5:3555. PubMed
  54. Nagaoka M, et al. 2014. J Immunol. 193:2812. PubMed
  55. Ni P, et al. 2014. Mol Immunol. 62:199. PubMed
  56. Charlton J, et al. 2015. PLoS One. 10:119200. PubMed
  57. Zhao Y, et al. 2015. PLoS One. 10: 0134797. PubMed
  58. Luck H, et al. 2015. Cell Metab. 21 527 . PubMed
  59. Jeon Y, et al. 2015. PLoS One. 10: e0139845. PubMed
  60. Yu H, et al. 2015. PLoS One. 10: 0143001. PubMed
  61. Su N, Xiong Y 2016. Sci Rep. 6:22658. PubMed
  62. Du C, et al. 2016. Nat Commun. 7: 11120. PubMed
  63. Kang J, Lee J, Chang J 2016. PLoS One. 11: 0157015. PubMed
  64. Yasuoka T, et al. 2016. PLoS One. 11: 0157395. PubMed
  65. Chou T, et al. 2016. Nat Commun. 7:11904. PubMed
  66. Li X, et al. 2016. MBio. 7: 02232-15. PubMed
  67. Wagner V, et al. 2016. Sci Transl Med. 8: 366ra164. PubMed
  68. D Kim, S Lee, H Jun 2016. Immunol Cell Biol. 10.1038/icb.2016.98. PubMed
  69. Miura N, et al. 2017. Mol Ther. 10.1016/j.ymthe.2017.01.020. PubMed
RRID
AB_315463 (BioLegend Cat. No. 506903)
AB_315464 (BioLegend Cat. No. 506904)

Antigen Details

Structure
Cytokine; dimer; 15 kD (Mammalian).
Bioactivity
Secretion of IL-6, IL-8, G-CSF, prostaglandin E2 by epithelial, endothelial or fibroblastic cells; stimulates cell migration, cord formation, and IL-6 secretion by stromal cells
Cell Sources
CD4+ memory T cells
Cell Targets
Fibroblasts, epithelial and endothelial cells, stromal cells
Receptors
IL-17R (CD217)
Biology Area
Cell Biology, Immunology, Neuroinflammation, Neuroscience
Molecular Family
Cytokines/Chemokines
Antigen References

1. Fitzgerald K, et al. Eds. 2001. The Cytokine FactsBook. Academic Press San Diego.
2. Numasaki M, et al. 2002. Blood 101:2620.
3. Fossiez F, et al. 1996. J. Exp. Med. 183:2593.
4. Yao Z, et al. 1997. Cytokine 9:794.
5. Dong C. 2006. Nat. Rev. Immunol. 6:329.
6. Hofstetter HH, et al. 2005 Cell. Immunol. 237:123.

Gene ID
16171 View all products for this Gene ID
UniProt
View information about IL-17A on UniProt.org

Related FAQs

Does the anti-mouse IL-17 antibody (clone TC11-18H10.1) recognize the A or F isoform?
Clone TC11-18H10.1 recognizes IL-17A isoform, but it also recognizes the IL-17A/F heterodimer via IL-17A binding.
What type of PE do you use in your conjugates?
We use R-PE in our conjugates.
Go To Top Version: 2    Revision Date: 10/16/2014

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Insert Note Here
Save Close Clear
Lab Timer
Tools
Login/Register
Remember me
Forgot your password? Reset Password
Request an Account